Ratings Nu Skin Enterprises, Inc.

Equities

NUS

US67018T1051

Market Closed - Nyse Other stock markets 04:00:02 2024-05-13 pm EDT			5-day change	1st Jan Change
13.51 ^USD	+2.19%		+10.74%	-30.43%

May. 09	DA Davidson Adjusts Nu Skin Enterprises' Price Target to $12.50 From $15.50, Keeps Neutral Rating	MT
May. 08	Transcript : Nu Skin Enterprises, Inc., Q1 2024 Earnings Call, May 08, 2024

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.48 for the 2024 fiscal year.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company does not generate enough profits, which is an alarming weak point.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Personal Products

	1st Jan change	Capi.	ESG Refinitiv
NU SKIN ENTERPRISES, INC.	-30.43%	657M	C+
PROCTER & GAMBLE COMPANY	+13.19%	394B	C-
UNILEVER PLC	+13.53%	134B	B-
COLGATE-PALMOLIVE COMPANY	+18.50%	78.02B	A+
HINDUSTAN UNILEVER LIMITED	-11.38%	66.3B	A-
ESTEE LAUDER	-7.89%	47.33B	B+
KENVUE INC.	-5.43%	39.33B	-
BEIERSDORF	+8.33%	35.5B	B-
ESSITY AB	+12.28%	18.09B	A-
GODREJ CONSUMER PRODUCTS LIMITED	+18.31%	16.17B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes